• Japan’s M&A Boom

    Japan's acquisitions market has seen surprising growth in recent times, as generic drugs increase in popularity. Frances Penwill-Cook takes a closer look at what Japanese pharma companies are buying and...

  • The Future for Biotesting

    The pharmaceutical industry's annual CPhI exhibition is approaching, showcasing the latest innovation and development. Natalie Coomber speaks to Dr Ivana Surovà, executive manager of business development at Biotest about the...

  • The Biotech Effect

    Catherine Lafferty looks at the rising influence of biotech on the renewed focus of pharmaceutical manufacturing.

  • Beating the Big C

    The global market for cancer drugs is growing rapidly, but are we any closer to beating this often fatal disease? Paul French investigates.

  • Amendments Set to Clear Ambiguity

    The US government is imposing transparency rules on the relationship between physicians and pharmaceutical companies. But are the major players ready to handle this? Penny Jones reports.

  • Tracking the Drug Trail

    Counterfeiting and fraud are significantly large risk factors when it comes to the safety of pharmaceutical products. Huw Kidwell follows the latest in developments in the pharmaceutical supply chain that...


Go Top